340 related articles for article (PubMed ID: 11845401)
1. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections].
Elies W
Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401
[TBL] [Abstract][Full Text] [Related]
2. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.
Anon JB
Paediatr Drugs; 2003; 5 Suppl 1():25-33. PubMed ID: 14632103
[TBL] [Abstract][Full Text] [Related]
3. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
Jang CH; Park SY
Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
[TBL] [Abstract][Full Text] [Related]
4. [Local treatment of Pseudomonas infection of the ear. A small clinical study].
Stange G
Laryngorhinootologie; 1989 Dec; 68(12):653-6. PubMed ID: 2514697
[TBL] [Abstract][Full Text] [Related]
5. [Otitis externa maligna. Report of a case resistant to ciprofloxacin].
Kindelan JM; Jurado R; No-Louis E; López-Villarejo P
Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):657. PubMed ID: 1822159
[No Abstract] [Full Text] [Related]
6. [Bacterial otitis externa with invasion of organ limits--systemic and local combination treatment with ciprofloxacin].
Ganz H
Z Arztl Fortbild (Jena); 1993 Apr; 87(5):413-5. PubMed ID: 8322469
[No Abstract] [Full Text] [Related]
7. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R
Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
[TBL] [Abstract][Full Text] [Related]
8. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa.
Bernstein JM; Holland NJ; Porter GC; Maw AR
J Laryngol Otol; 2007 Feb; 121(2):118-23. PubMed ID: 16995959
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa.
Mekić S; Matanović K; Šeol B
Vet Rec; 2011 Jul; 169(5):125. PubMed ID: 21742683
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial treatment of otitis media.
Giebink GS; Canafax DM
Semin Respir Infect; 1991 Jun; 6(2):85-93. PubMed ID: 1771307
[TBL] [Abstract][Full Text] [Related]
11. [Monotherapy of systematic Pseudomonas aeruginosa infections with ceftazidime. The causes of therapeutic failures].
Blaser J; Bauernfeind A; Vogt M; Lüthy R
Dtsch Med Wochenschr; 1983 Sep; 108(35):1312-7. PubMed ID: 6411442
[TBL] [Abstract][Full Text] [Related]
12. Acute otitis media in pediatric medicine: current issues in epidemiology, diagnosis, and management.
Leibovitz E
Paediatr Drugs; 2003; 5 Suppl 1():1-12. PubMed ID: 14632101
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin for the treatment of chronic ear disease.
Piccirillo JF; Parnes SM
Laryngoscope; 1989 May; 99(5):510-3. PubMed ID: 2651829
[TBL] [Abstract][Full Text] [Related]
14. Initial management of necrotizing external otitis: errors to avoid.
Guevara N; Mahdyoun P; Pulcini C; Raffaelli C; Gahide I; Castillo L
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):115-21. PubMed ID: 23276814
[TBL] [Abstract][Full Text] [Related]
15. ENT manifestations of Pseudomonas aeruginosa infection in HIV and AIDS.
Hern JD; Ghufoor K; Jayaraj SM; Frosh A; Mochloulis G
Int J Clin Pract; 1998; 52(3):141-4. PubMed ID: 9684426
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa in chronic suppurative otitis media: sensitivity spectrum against various antibiotics in Karachi.
Mansoor T; Musani MA; Khalid G; Kamal M
J Ayub Med Coll Abbottabad; 2009; 21(2):120-3. PubMed ID: 20524487
[TBL] [Abstract][Full Text] [Related]
17. Microbiology of otitis externa in the secondary care in United Kingdom and antimicrobial sensitivity.
Ninkovic G; Dullo V; Saunders NC
Auris Nasus Larynx; 2008 Dec; 35(4):480-4. PubMed ID: 18314283
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
[TBL] [Abstract][Full Text] [Related]
19. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy.
Wright A; Hawkins CH; Anggård EE; Harper DR
Clin Otolaryngol; 2009 Aug; 34(4):349-57. PubMed ID: 19673983
[TBL] [Abstract][Full Text] [Related]
20. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
